Perinatal Epidermal Growth Factor Receptor Blockade Prevents Peripheral Nerve Disruption in a Mouse Model Reminiscent of Benign World Health Organization Grade I Neurofibroma-Reference-Cited by-同舟云学术

Perinatal Epidermal Growth Factor Receptor Blockade Prevents Peripheral Nerve Disruption in a Mouse Model Reminiscent of Benign World Health Organization Grade I Neurofibroma

Published:2006-05 Issue:5 Volume:168 Page:1686-1696
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Wu Jianqiang,Crimmins Jason T.,Monk Kelly R.,Williams Jon P.,Fitzgerald Maureen E.,Tedesco Susan,Ratner Nancy

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Neurofibromatosis and childhood tumors;Blatt;Cancer,1986

2. Epidemiology of neurofibromatosis type 1;Friedman;Am J Med Genet,1999

3. Neurofibromatosis type 1: historical perspective and introductory overview;Huson,1998

4. The Neurofibromatosis;Huson,1994

5. Neurological complications of neurofibromatosis type 1 in adulthood;Creange;Brain,1999

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed Tomography–Based Differentiation of Benign and Malignant Craniofacial Lesions in Neurofibromatosis Type I Patients: A Machine Learning Approach;Frontiers in Oncology;2020-07-31

2. The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis;Neuro-Oncology Advances;2019-12-31

3. Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice;JCI Insight;2019-02-07

4. Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy;Oncotarget;2017-05-30

5. EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation;Oncogene;2016-10-17